Related Experiment Video
Updated: May 5, 2026

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
Phased high-quality genome of the gymnosperm Himalayan Yew assists in paclitaxel pathway exploration
Zhenzhu Li1, Hang Zong1, Xiaonan Liu2,3
1New Cornerstone Science Laboratory, Shaanxi Key Laboratory of Qinling Ecological Intelligent Monitoring and Protection, School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Background:
Taxus wallichiana is an important species for paclitaxel production. Previous genome versions for Taxus spp. have been limited by extensive gaps, hindering the complete annotation and mining of paclitaxel (known as Taxol commercially) synthesis pathway-related genes.
Results:
Here, we present the first phased high-quality reference genome of T. wallichiana, which significantly improves assembly quality and corrects large-scale assembly errors present in previous versions. The 2 haplotypes are 9.87 Gb and 9.98 Gb in length, respectively, and all 24 chromosomes were assembled with telomeres at both ends. Based on this high-quality genome (TWv1), we inferred that the candidate sex chromosome of T. wallichiana is chr12, and its sex determination system may follow a ZW model. Particularly, we identified and experimentally validated a batch of 2-oxoglutarate/Fe(II)-dependent dioxygenases (ODDs), which may be key C4β-C20 epoxidases in the paclitaxel synthesis pathway.
Conclusions:
This study not only provides a valuable data resource for gene mining in the biosynthetic pathways of secondary metabolites, such as paclitaxel, but also offers the highest-quality reference genome of gymnosperms to date for the identification of sex chromosomes, facilitating comparative genomic studies among gymnosperms.
More Related Videos
13:03Robust DNA Isolation and High-throughput Sequencing Library Construction for Herbarium Specimens
Published on: March 8, 2018
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023